Shattuck Labs, Inc.
STTK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680367
In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Shattuck Labs, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 48 | 49 | +1 |
| Shares | 20.4M | 20.3M | −86.6K (−0.4%) |
| Value | $46.9M | $59.7M | +$12.8M (+27.4%) |
New holders (5)
Institutions that held Shattuck Labs, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 26,479 | $77.8K | 0.00% |
| Susquehanna International Group, LLP | 24,683 | $72.6K | 0.00% |
| Jane Street Group, LLC | 19,765 | $58.1K | 0.00% |
| Man Group plc | – | $42.0K | 0.00% |
| Squarepoint Ops LLC | 10,371 | $30.5K | 0.00% |
Sold out (4)
Institutions that held Shattuck Labs, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Gsa Capital Partners LLP | 47,183 | $109.0K |
| Prudential Financial Inc | 16,250 | $37.4K |
| Cubist Systematic Strategies, LLC | 11,960 | $27.5K |
| Citigroup Inc | 107 | $246 |